Baron M, Hudson M, Steele R, Lo E, and the Canadian Scleroderma Research Group. Validation of the UCLA Scleroderma Clinical Trial Gastrointestinal Tract Instrument Version 2.0 for systemic sclerosis. J Rheumatol 2011;38: 1925–30. The second sentence of the Results section of the Abstract should read as follows: The overall score of the instrument correlated well with the GI scale of the SSc-Health Assessment Questionnaire (GI-S-HAQ) (r = 0.58, p < 0.001) and with the total number of GI symptoms (r = 0.77, p < 0.001). We regret the error.